Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-646-6 | CAS number: 123-72-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Genetic toxicity
In Vitro Studies
In a study sponsored by the NTP, butyraldehyde was negative in the Salmonella/mammalian microsome mutagenicity assay when evaluated as a coded chemical in two test laboratories (Mortelmans et al. 1986; Dillon et al. 1988): It was tested in five tester strains (TA97, TA98, TA100, TA1535, TA1537) using the pre-incubation assay with a minimum of five non-toxic concentrations ranging from 33 to 3333 µg/plate, in the presence and absence of Arochlor-induced rat and hamster liver S-9 metabolic activation. Sasaki and Endo (1978) also reported negative mutagenicity results in Salmonella tester strains TA98 and TA100 in a pre-incubation assay with and without rat S-9 metabolic activation. The dose range tested was not reported.
When tested in Chinese hamster ovary (CHO) cells, butryaldehyde did not increase the incidence of chromosomal aberrations at concentrations ranging from 59 to135 µg/ml with and without rat S-9 activation (Galloway et al 1987). In addition, butyraldehyde was negative for sister chromatid exchange in human lymphocytes when tested in the absence of metabolic activation (Obe and Beek 1979).
Butyraldehyde was positive for induction of sister chromatid exchange in CHO cells when tested in the presence and absence of metabolic activation at nontoxic doses ranging from 9 to 90 µg/ml (Galloway et al 1987).
There was an increase in the incidence of mutations at the HGPRT and Na/K ATPase loci in Chinese hamster V79 cells exposed to butyraldehyde at concentrations up to 648 µg/ml in the absence of metabolic activation (Brambilla et al. 1989). In studies utilizing primary rat and human hepatocytes, exposure to butyraldehyde at concentrations up to 2163 µg/ml did not result in an increase in DNA repair (Martelli et al. 1994). BASF (1999) reported a negative result when testing the structurally related isobutyraldehyde in the CHO cell HPRT forward mutation assay with and without metabolic activation under GLP conditions (OECD guideline 476),detailed information can be found in the isobutyraldehyde CAS 78-84-2 dossier.
In Vivo Studies: Evaluation negative
Moutschen-Dahmen et al (1975, 1976) reported that male Q strain mice displayed mortality (LD50 was 1140 mg/kg, i.p.), and evidence of cell degeneration, polyploidy during spermatogenesis, and chromosomal aberrations and modifications in sperm morphology when injected intraperitoneally (i.p.) with a single dose of 1 mg per animal (approximate dose 30 mg/kg) or exposed to the chemical in drinking water ( 2 g/L) for 50 days (total dose 15 g/kg or about 300 mg/kg bw/d)]. Meiotic anomalies consisting of degenerative nuclei, multispindle cells, and polyploidy were observed at all stages of spermatogenesis in exposed mice. This test series is considered unreliable due to severe deficiencies in methodology and in documentation.
A micronucleus assay in mice reportedly gave no evidence of clastogenic/genotoxic activity of butyraldehyde (NTP Testing Status 2007). Butyraldehyde was negative when tested in the sex-linked recessive lethal test in Drosophilia (SLRL). Male flies were injected with 10,000 ppm butyraldehyde or fed butyraldehyde in a 0.7% sucrose solution (Valencia et al. 1985).
Genetic toxicity studies
Test | Test System | Result | Reference | Evaluation |
In-Vitro Assays | ||||
Ames | S. typh. (strains TA100, TA1535, TA1537, TA-98) (TA 100, TA 102, TA 104) | Negative with and without metabolic activation | Mortelmans et al. 1986; Dillon et al. 1988 | Rel 2 |
Ames | S. typh. (strains TA98; TA100, TA1535, TA1537, TA1538) | Negative with and without S9 | Litton Bionetics 1978 | Rel 3 (identity) |
Ames | S. typh. (strains TA98; TA100, TA1535, TA1537) | Negative with and without metabolic activation | Florin et al., 1980 | Rel 3 (too low dose) |
Ames | S. typh. (strains TA98; TA100) | Negative with and without metabolic activation | Sasaki and Endo 1978 | Rel 4 (not available) |
Gene mutations (mammalian cell) | HGPRT locus, Na/K locus, Chinese hamster lung fibroblasts (V79) in vitro | Positive without metabolic activation | Brambilla et al. 1989 | Rel 4 (secondary source) |
Chromosomal aberrations | Chinese hamster ovary cells; in vitro | negative with and without metabolic activation | Galloway et al. 1987 (see also NTP Testing Status) | Rel 4 (secondary source) |
Sister chromatid exchanges | Chinese hamster ovary cells; in vitro | Positive with and without metabolic activation | Galloway et al. 1987 (see also NTP Testing Status) | Rel 4 (secondary source) |
Sister chromatid exchanges | Chinese hamster ovary cells; in vitro | Negative without metabolic activation | Obe and Beek | Rel 3 (secondary source, deficiencies) |
DNA repair | Primary hepatocyrte culture (rat + human) | Negative | Martelli et al. 1994 | Rel 4 (secondary source) |
In-Vivo Assays | ||||
Chromosomal aberrations | Mouse, male, spermatogenesis, in vivo, i.p., single dose | Positive | Moutschen- Dahmen et al. 1975, 1976 | Rel 3 (secondary literature) |
Chromosomal aberrations | Mouse, male, spermatogenesis, in vivo, drinking water,50 d | Positive | Moutschen-Dahmen et al. 1976 | Rel 3 (secondary literature) |
Erythrocyte micronucleus assay | Mouse, bone marrow; in vivo | Negative | NTP Testing Status | Rel 2 (secondary source, not availalable yet) |
Gene mutations SLRL | Drosophila melanogaster; in vivo (oral + injection) | Negative | Valencia et al. 1985 (see also NTP Testing Status) | Rel 2 (secondary source) |
Short description of key information:
The genotoxicity of the substance has been evaluated in an appropriate battery of studies in vitro and in vivo. Negative results are reported for bacterial reverse mutation in two Ames tests. Negative results are also reported for investigations of chromosomal aberration and SCE in mammalian cells in vitro, however positive results are reported in an additional study of SCE and also in an HPRT assay. USD assays in primary rat and human hepatocytes report negative results. In vivo, published studies in Drosophila report positive results; these are in contrast to negative results in a high quality (NTP) SLRL study. A further NTP study reports a negative result for the induction of micronuclei in mouse bone marrow. The weight of evidence therefore suggests that the substance in not genotoxic in vivo in mammalian systems
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
The genotoxicity of the substance has been evaluated in an appropriate battery of studies in vitro and in vivo. Negative results are reported for bacterial reverse mutation in two Ames tests. Negative results are also reported for investigations of chromosomal aberration and SCE in mammalian cells in vitro, however positive results are reported in an additional study of SCE and also in an HPRT assay. USD assays in primary rat and human hepatocytes report negative results. In vivo, published studies in Drosophila report positive results; these are in contrast to negative results in a high quality (NTP) SLRL study. A further NTP study reports a negative result for the induction of micronuclei in mouse bone marrow. The weight of evidence therefore suggests that the substance is not genotoxic in vivo in mammalian systems and does not require classification for genetic toxicity according to Directive 67/548/EEC or Regulation 1272/2008/EC (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live1